Abstract
Intra-aortic balloon pump (IABP) counterpulsation has been the most widely used circulatory assist device for nearly five decades. As a result of diastolic inflation and systolic deflation, coronary blood flow is increased and afterload decreased translating into augmentation of oxygen supply and lowering of oxygen demand. In routine clinical practice, IABP is mainly used in high-risk patients with acute myocardial infarction, especially when complicated by cardiogenic shock. Further, prophylactic IABP is frequently used in patients at high risk for hemodynamic instability undergoing elective percutaneous coronary intervention or coronary artery bypass grafting. However, IABP use may be associated with serious complications, including major bleeding, thromboembolism, stroke, and vascular complications. The potential benefits of IABP must be weighed against these serious complications. This chapter describes mechanism of action, indications and contraindications for use of the IABP, insertion and timing of the device, and troubleshooting measures for common malfunctions.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Kantrowitz A, Tjonneland S, Freed PS, Phillips SJ, Butner AN, Sherman JL. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA. 1968;203:113–8.
Mayer JH. Subclavian artery approach for insertion of intra-aortic balloon. J Thorac Cardiovasc Surg. 1978;76:61–3.
McBride LR, Miller LW, Naunheim KS, Pennington DG. Axillary artery insertion of an intraaortic balloon pump. Ann Thorac Surg. 1989;48:874–5.
Krishna M, Zacharowski K. Principles of intra-aortic balloon pump counterpulsation. Contin Educ Anaesth Crit Care Pain. 2009;9:24–8.
Ntalianis A, Kapelios CJ, Kanakakis J, et al. Prolonged intra-aortic balloon pump support in biventricular heart failure induces right ventricular reverse remodeling. Int J Cardiol. 2015;192:3–8.
Thiele H, Zeymer U, Neumann F-J, et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet. 2013;382:1638–45.
Unverzagt S, Buerke M, de Waha A, et al. Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock. Cochrane Database Syst Rev. 2015;75:CD007398.
Castleberry AW, DeVore AD, Southerland KW, et al. Assessing consequences of intraaortic balloon counterpulsation versus left ventricular assist devices at the time of heart transplantation. ASAIO J. 2016;62:232–9.
Nwaejike N, Campalani G, Gladstone D, Nzewi OC. Benefits of the preemptive intra-aortic balloon pump: an audit of practice in a regional cardiothoracic center. Heart Surg Forum. 2009;12:E70–4.
Stenz R. Intra-aortic balloon counterpulsation. Anaesth Intens Care Med. 2006;7:335–6.
Nwaejike N, Son AY, Patel CB, Schroder JN, Milano CA, Daneshmand MA. The axillary intra-aortic balloon pump as a bridge to recovery allows early ambulation in long-term use: case series and literature review. Innovations (Philadelphia, PA). 2017;12:472–8.
Raman J, Loor G, London M, Jolly N. Subclavian artery access for ambulatory balloon pump insertion. Ann Thorac Surg. 2010;90:1032–4.
Nwaejike N, Son AY, Milano CA, Daneshmand MA. Is there a role for upper-extremity intra-aortic balloon counterpulsation as a bridge-to-recovery or a bridge-to-transplant in the treatment of end-stage heart failure? Interact Cardiovasc Thorac Surg. 2017;25:654–8.
Vales L, Kanei Y, Ephrem G, Misra D. Intra-aortic balloon pump use and outcomes with current therapies. J Invasive Cardiol. 2011;23:116–9.
Parissis H, Soo A, Al-Alao B. Intra aortic balloon pump: literature review of risk factors related to complications of the intraaortic balloon pump. J Cardiothorac Surg. 2011;6:147.
Manord JD, Garrard CL, Mehra MR, et al. Implications for the vascular surgeon with prolonged (3 to 89 days) intraaortic balloon pump counterpulsation. J Vasc Surg. 1997;26:511–5.
Jiang CY, Zhao LL, Wang JA, Mohammod B. Anticoagulation therapy in intra-aortic balloon counterpulsation: does IABP really need anti-coagulation? J Zhejiang Univ Sci. 2003;4:607–11.
Pucher PH, Cummings IG, Shipolini AR, McCormack DJ. Is heparin needed for patients with an intra-aortic balloon pump? Interact Cardiovasc Thorac Surg. 2012;15:136–9.
Webb CA, Weyker PD, Flynn BC. Management of intra-aortic balloon pumps. Semin Cardiothorac Vasc Anesth. 2015;19:106–21.
Nash IS, Lorell BH, Fishman RF, Baim DS, Donahue C, Diver DJ. A new technique for sheathless percutaneous intraaortic balloon catheter insertion. Catheter Cardiovasc Diagn. 1991;23:57–60.
Erdogan HB, Goksedef D, Erentug V, et al. In which patients should sheathless IABP be used? An analysis of vascular complications in 1211 cases. J Card Surg. 2006;21:342–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Nwaejike, N., Daneshmand, M.A. (2020). Intra-aortic Balloon Pump. In: Raja, S. (eds) Cardiac Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-24174-2_67
Download citation
DOI: https://doi.org/10.1007/978-3-030-24174-2_67
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-24173-5
Online ISBN: 978-3-030-24174-2
eBook Packages: MedicineMedicine (R0)